General MedicationsORALStandard

SILDENAFIL CITRATE

Standard Dose

EQ 20MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview SILDENAFIL CITRATE is listed in Drugs@FDA under application 210394 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient SILDENAFIL CITRATE Form and strength TABLET;ORAL - EQ 20MG BASE Sponsor AJANTA PHARMA LTD Submission history Latest submission status date: 2025-03-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview SILDENAFIL CITRATE is listed in Drugs@FDA under application 210394 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SILDENAFIL CITRATE Form and strength TABLET;ORAL - EQ 20MG BASE Sponsor AJANTA PHARMA LTD Submission history Latest submission status date: 2025-03-24 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.